Cresco Labs Revenue 2020-2025 | CRLBF
Cresco Labs revenue from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Cresco Labs Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $724 |
| 2023 | $771 |
| 2022 | $843 |
| 2021 | $822 |
| 2020 | $476 |
| 2019 | $129 |
|
Cresco Labs Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $165 |
| 2025-06-30 | $164 |
| 2025-03-31 | $166 |
| 2024-12-31 | $176 |
| 2024-09-30 | $180 |
| 2024-06-30 | $184 |
| 2024-03-31 | $184 |
| 2023-12-31 | $188 |
| 2023-09-30 | $191 |
| 2023-06-30 | $198 |
| 2023-03-31 | $194 |
| 2022-12-31 | $200 |
| 2022-09-30 | $210 |
| 2022-06-30 | $218 |
| 2022-03-31 | $214 |
| 2021-12-31 | $218 |
| 2021-09-30 | $215 |
| 2021-06-30 | $210 |
| 2021-03-31 | $178 |
| 2020-12-31 | $162 |
| 2020-09-30 | $153 |
| 2020-06-30 | $94 |
| 2020-03-31 | $66 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.497B | $0.724B |
| Cresco Labs Inc. is an integrated multistate cannabis operators principally in the United States. Its brands are designed to meet the needs of all consumer segments and comprised of brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Cresco Labs Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.733B | 24.98 |
| EssilorLuxottica (ESLOY) | France | $149.439B | 0.00 |
| Boston Scientific (BSX) | United States | $141.899B | 32.45 |
| Stryker (SYK) | United States | $138.196B | 27.44 |
| Medtronic (MDT) | Ireland | $124.291B | 17.22 |
| Medline (MDLN) | United States | $56.122B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Agilent Technologies (A) | United States | $41.955B | 26.52 |
| GE HealthCare Technologies (GEHC) | United States | $39.585B | 18.93 |
| ResMed (RMD) | United States | $37.629B | 26.04 |
| Koninklijke Philips (PHG) | Netherlands | $28.695B | 18.74 |
| Terumo (TRUMY) | Japan | $21.868B | 24.62 |
| Insulet (PODD) | United States | $19.595B | 60.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.124B | 11.30 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.309B | 0.00 |
| Baxter (BAX) | United States | $10.358B | 8.36 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.713B | 31.33 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| BillionToOne (BLLN) | United States | $4.538B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.475B | 13.63 |
| Haemonetics (HAE) | United States | $3.881B | 17.27 |
| Envista Holdings (NVST) | United States | $3.844B | 22.06 |
| ICU Medical (ICUI) | United States | $3.732B | 23.70 |
| Prestige Consumer Healthcare (PBH) | United States | $3.140B | 14.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.266B | 14.57 |
| Perrigo (PRGO) | Ireland | $2.056B | 5.15 |
| Neogen (NEOG) | United States | $2.038B | 44.62 |
| LeMaitre Vascular (LMAT) | United States | $1.902B | 38.28 |
| AtriCure (ATRC) | United States | $1.871B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.845B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.819B | 79.73 |
| Phibro Animal Health (PAHC) | United States | $1.614B | 16.13 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.496B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.436B | 20.78 |
| Kestra Medical Technologies (KMTS) | United States | $1.366B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.157B | 343.43 |
| Capricor Therapeutics (CAPR) | United States | $1.121B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.044B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.007B | 0.00 |
| InMode (INMD) | Israel | $0.916B | 10.35 |
| Omeros (OMER) | United States | $0.909B | 0.00 |
| CeriBell (CBLL) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.840B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.558B | 15.12 |
| Verano Holdings (VRNO) | United States | $0.489B | 0.00 |
| Brainsway (BWAY) | Israel | $0.474B | 80.63 |
| Canopy Growth (CGC) | Canada | $0.453B | 0.00 |
| SNDL (SNDL) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.436B | 0.00 |
| Evolus (EOLS) | United States | $0.374B | 0.00 |
| Quanterix (QTRX) | United States | $0.344B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.293B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TerrAscend (TSNDF) | Canada | $0.259B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.241B | 142.00 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.213B | 0.00 |
| Accendra Health (ACH) | United States | $0.207B | 2.08 |
| Vireo Growth (VREOF) | United States | $0.204B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.192B | 16.92 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Exagen (XGN) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.75 |
| Biote (BTMD) | United States | $0.115B | 5.02 |
| MacroGenics (MGNX) | United States | $0.113B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.65 |
| Sharps Technology (STSS) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 34.92 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.47 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |